glp-1 drugs eli lilly says its experimental pill better than Novo's Rybelsus in diabetes study Why Eli Lilly is suddenly
Description
2012;7:e51870
Mounjaro is a once-weekly injection containing tirzepatide, which targets two hormones, GLP-1 and GIP , and it's shown the strongest average weight loss results in clinical trials, at around 22.5% over 72 weeks
[DOI] [PubMed] [Google Scholar] [6].Baggio LL, Drucker DJ, Biology of incretins: GLP-1 and GIP, Gastroenterology, 132 (2007) 21312157
User feedback and available product information reveal consistent themes across both positive experiences and common complaints
